keyword
https://read.qxmd.com/read/38630156/anti-obesity-potentiality-of-lactiplantibacillus-plantarum-e2_mcckt-isolated-from-a-fermented-beverage-haria-a-high-fat-diet-induced-obese-mice-model-study
#1
JOURNAL ARTICLE
Tridip Kumar Das, Priyanka Kar, Titli Panchali, Amina Khatun, Ananya Dutta, Smita Ghosh, Sudipta Chakrabarti, Shrabani Pradhan, Keshab Chandra Mondal, Kuntal Ghosh
Obesity is a growing epidemic worldwide. Several pharmacologic drugs are being used to treat obesity but these medicines exhibit side effects. To find out the alternatives of these drugs, we aimed to assess the probiotic properties and anti-obesity potentiality of a lactic acid bacterium E2_MCCKT, isolated from a traditional fermented rice beverage, haria. Based on the 16S rRNA sequencing, the bacterium was identified as Lactiplantibacillus plantarum E2_MCCKT. The bacterium exhibited in vitro probiotic activity in terms of high survivability in an acidic environment and 2% bile salt, moderate auto-aggregation, and hydrophobicity...
April 17, 2024: World Journal of Microbiology & Biotechnology
https://read.qxmd.com/read/38581564/effectiveness-of-saccharomyces-boulardii-cncm-i-745-in-adult-indian-patients-with-diarrhoea-a-real-world-multicentre-retrospective-comparative-study
#2
JOURNAL ARTICLE
Bhaskar Bikash Pal, Rupali Vinodchandra Bandagi, Kranthi Kiran Pebbili, Rahul Rathod, Bhavesh Kotak, Gauri Dhanaki, Snehal Shah
BACKGROUND: Multiple clinical studies have described the benefits of probiotic Saccharomyces boulardii (S. boulardii) CNCM I-745 against diarrhoea, but the real-world evidence supporting its use is lacking. OBJECTIVE: To evaluate effectiveness of the S. boulardii CNCM I-745 group in a real-world setting. METHODS: This was an electronic medical record (EMR)-based, retrospective, multicentre, comparative study in Indian adult patients presenting with diarrhoea managed between January 2020 and January 2022...
April 6, 2024: Drugs—Real World Outcomes
https://read.qxmd.com/read/38569427/adjunctive-administration-of-parabiotic-lactobacillus-sakei-cvl-001-ameliorates-drug-induced-toxicity-and-pulmonary-inflammation-during-antibiotic-treatment-for-tuberculosis
#3
JOURNAL ARTICLE
Hagyu Kim, Eun-Jung Song, Eunsol Choi, Kee Woong Kwon, Jong-Hwan Park, Sung Jae Shin
Tuberculosis (TB) treatment requires a long therapeutic duration and induces adverse effects such as hepatotoxicity, causing discontinuation of treatment. Reduced adherence to TB medications elevates the risk of recurrence and the development of drug resistance. Additionally, severe cavitary TB with a high burden of Mycobacterium tuberculosis (Mtb) and inflammation-mediated tissue damage may need an extended treatment duration, resulting in a higher tendency of drug-induced toxicity. We previously reported that the administration of Lactobacillus sakei CVL-001 (L...
April 2, 2024: International Immunopharmacology
https://read.qxmd.com/read/38555366/untargeted-metabolomics-based-network-pharmacology-reveals-fermented-brown-rice-towards-anti-obesity-efficacy
#4
JOURNAL ARTICLE
Kaliyan Barathikannan, Ramachandran Chelliah, Annadurai Vinothkanna, Ragothaman Prathiviraj, Akanksha Tyagi, Selvakumar Vijayalakshmi, Min-Jin Lim, Ai-Qun Jia, Deog- Hwan Oh
There is a substantial rise in the global incidence of obesity. Brown rice contains metabolic substances that can help minimize the prevalence of obesity. This study evaluated nine brown rice varieties using probiotic fermentation using Pediococcus acidilacti MNL5 to enhance bioactive metabolites and their efficacy. Among the nine varieties, FBR-1741 had the highest pancreatic lipase inhibitory efficacy (87.6 ± 1.51%), DPPH assay (358.5 ± 2.80 mg Trolox equiv./100 g, DW), and ABTS assay (362...
March 30, 2024: NPJ science of food
https://read.qxmd.com/read/38554932/therapeutic-potential-of-lipid-lowering-probiotics-on-the-atherosclerosis-development
#5
REVIEW
Mohamed J Saadh, Behina Bazghandi, Hamid Jamialahmdi, Fatemeh Rahimzadeh-Bajgiran, Fatemeh Forouzanfar, Seyed-Alireza Esmaeili, Ehsan Saburi
Hypercholesterolemia is a critical risk factor for atherosclerosis, mostly attributed to lifestyle behavior such as diet. Recent advances have emphasized the critical effects of gastrointestinal bacteria in the pathology of hypercholesterolemia and atherosclerosis, suggesting that the gastrointestinal microbiome can therefore provide efficient therapeutic targets for preventing and treating atherosclerosis. Thus, interventions, such as probiotic therapy, aimed at altering the bacterial composition introduce a promising therapeutic procedure...
March 28, 2024: European Journal of Pharmacology
https://read.qxmd.com/read/38548440/pharmacologic-management-of-hepatic-encephalopathy
#6
REVIEW
Ali Khalessi, Nikolaos T Pyrsopoulos
Hepatic encephalopathy is a common cause of morbidity and mortality among patients with decompensated liver cirrhosis. In this article, we review the history, mechanism, and evidence for first-line pharmacologic therapies for hepatic encephalopathy including nonabsorbable disaccharides, antibiotics, and electrolyte management. We also review newer, second-line therapies including polyethylene glycol, albumin, branched-chain amino acids, probiotics and fecal microbiota transplant, zinc, and l-ornithine-l-aspartate...
May 2024: Clinics in Liver Disease
https://read.qxmd.com/read/38540897/milk-bioactive-compounds-and-gut-microbiota-modulation-the-role-of-whey-proteins-and-milk-oligosaccharides
#7
REVIEW
Valentina Gallo, Alyexandra Arienzo, Federica Tomassetti, Giovanni Antonini
A strong correlation between the occurrence of various pathological conditions and intestinal dysbiosis is supported by a range of strong evidence. Vice versa, many pathologies have been shown, in turn, to be responsible for alterations in the gut microbiota, a condition that can worsen illness outcomes and response to therapies. For these reasons, great efforts have been made, and studies are still ongoing, to elucidate the mechanisms underlying gut microbiota alterations and to search for pharmacologic or other strategies that can effectively restore the gut microbiota...
March 16, 2024: Foods (Basel, Switzerland)
https://read.qxmd.com/read/38535465/microencapsulation-of-lactobacillus-plantarum-with-improved-survivability-using-pufferfish-skin-gelatin-based-wall-materials
#8
JOURNAL ARTICLE
Honghui Guo, Yelin Zhou, Quanling Xie, Hui Chen, Yiping Zhang, Zhuan Hong, Sijin Chen, Ming'en Zhang
To improve the survivability of probiotics, Lactobacillus plantarum was microencapsulated using pufferfish skin gelatin (PSG)-based wall materials by spray-drying. This work investigated the protective effect of three different pH-dependent proteins (sodium caseinate (SC), soy protein isolate (SPI), and whey protein isolate (WPI)) combined with PSG on L. plantarum . The experimental results of spray-drying with an inlet temperature of 120 °C and an outlet temperature of 80 °C, storage at 4 °C for 6 months, simulated digestion, and turbidity indicated that PSG/SC had better stability and encapsulation effects and was more suitable to encapsulate L...
March 5, 2024: Marine Drugs
https://read.qxmd.com/read/38533255/editorial-research-challenges-of-drug-utilization-data-collection-data-validation-and-adverse-drug-reactions-in-neonates
#9
EDITORIAL
Robert M Ward
No abstract text is available yet for this article.
2024: Frontiers in Pharmacology
https://read.qxmd.com/read/38525049/gonorrhea-caused-due-to-antimicrobial-resistant-bacteria-neisseria-gonorrhoeae-treated-using-probiotic-peptide
#10
JOURNAL ARTICLE
Gokul Sudhakaran, D Kesavan, Madesh Selvam, Abirami Arasu, Ajay Guru, Jesu Arockiaraj
Neisseria gonorrhea is a sexually transmitted disease from gonorrhea that lacks treatment; despite the urgency, the absence of adequate drugs, lack of human correlates of protection, and inadequate animal models of infection have delayed progress toward the prevention of gonococcal infection. Lactobacillus crispatus is a lactic acid bacterium typically found in the human vaginal microbiota. Peptides from L. crispatus have shown a potential therapeutic option for targetting N. gonorrhea . Bioinformatics analysis is important for speeding up drug target acquisition, screening refinement, and evaluating adverse effects and drug resistance prediction...
2024: In Silico Pharmacology
https://read.qxmd.com/read/38504564/current-view-on-how-human-gut-microbiota-mediate-metabolic-and-pharmacological-activity-of-panax-ginseng-a-scoping-review
#11
JOURNAL ARTICLE
Monica Montagnani, Maria Assunta Potenza, Massimo Corsalini, Giuseppe Barile, Ioannis Alexandros Charitos, Andrea de Giacomo, Emilio Jirillo, Marica Colella, Luigi Santacroce
Panax ginseng is one of the most important remedies in ancient Eastern medicine. In the modern Western world, its reputation started to grow towards the end of the XIX century, but the rather approximate understanding of action mechanisms did not provide sufficient information for an appropriate use. Nowadays, Panax ginseng is frequently used in some pathological conditions, but the comprehension of its potential beneficial effects is still incomplete. The purpose of this study is to highlight the most recent knowledge on mechanisms and effects of ginseng active ingredients on the intestinal microbiota...
March 19, 2024: Endocrine, Metabolic & Immune Disorders Drug Targets
https://read.qxmd.com/read/38502301/migraine-and-the-microbiota-can-probiotics-be-beneficial-in-its-prevention-a-narrative-review
#12
REVIEW
Aneta Kiecka, Marian Szczepanik
Migraine is a recurrent disease of the central nervous system that affects an increasing number of people worldwide causing a continuous increase in the costs of treatment. The mechanisms underlying migraine are still unclear but recent reports show that people with migraine may have an altered composition of the intestinal microbiota. It is well established that the gut-brain axis is involved in many neurological diseases, and probiotic supplementation may be an interesting treatment option for these conditions...
March 19, 2024: Pharmacological Reports: PR
https://read.qxmd.com/read/38497853/clinical-effects-of-lactobacillus-reuteri-probiotic-in-chronic-periodontitis-a-systematic-review
#13
JOURNAL ARTICLE
J Ram, K H Awan, C M T Freitas, S Bhandi, F W Licari, S Patil
OBJECTIVE: This systematic review examines the effectiveness of Lactobacillus reuteri as an adjunct to scaling and root planing in the treatment of chronic periodontitis. MATERIALS AND METHODS: Scopus, PubMed, and Web of Science databases were searched according to specific inclusion and exclusion criteria in October 2022. Randomized control trials that evaluated the effects of Lactobacillus reuteri in patients with periodontitis were included. The primary outcome was pocket depth and clinical attachment levels, while the secondary outcome considered was bleeding on probing, microbial levels, and gingival index score...
March 2024: European Review for Medical and Pharmacological Sciences
https://read.qxmd.com/read/38497338/therapeutic-strategies-to-modulate-gut-microbial-health-approaches-for-sarcopenia-management
#14
REVIEW
Shreya Das, B Preethi, Sapana Kushwaha, Richa Shrivastava
Sarcopenia is a progressive and generalized loss of skeletal muscle and functions associated with ageing with currently no definitive treatment. Alterations in gut microbial composition have emerged as a significant contributor to the pathophysiology of multiple diseases. Recently, its association with muscle health has pointed to its potential role in mediating sarcopenia. The current review focuses on the association of gut microbiota and mediators of muscle health, connecting the dots between the influence of gut microbiota and their metabolites on biomarkers of sarcopenia...
March 6, 2024: Histology and Histopathology
https://read.qxmd.com/read/38495822/scoping-review-of-obesity-interventions-research-frontiers-and-publication-status
#15
REVIEW
Longhao Zhang, Shuang Dai, Yufei Chen, Tingting Jin, Wei Li, Wen Wang, Jian Pu, Peng Jia, Li Zhao, Xin Sun
Obesity and overweight are significant global health issues, and numerous obesity intervention studies have been conducted. Summarizing current knowledge of interventions aims to inform researchers and policymakers to keep up-to-date with the latest scientific advancements and trends. In this review, we comprehensively retrieved and screened 4,541 studies on obesity intervention published between 2018 and 2022 in the Web of Science Core Collection, and objectively presented research frontiers using bibliometric analysis...
April 19, 2024: IScience
https://read.qxmd.com/read/38490297/the-role-of-gut-microbiota-and-probiotics-in-preventing-treating-and-boosting-the-immune-system-in-colorectal-cancer
#16
REVIEW
Forough Masheghati, Mohammad Reza Asgharzadeh, Abbas Jafari, Naser Masoudi, Hadi Maleki-Kakelar
The gut microbiome plays a significant role in developing colorectal cancer (CRC). The gut microbiome usually acts as a protective barrier against harmful pathogens and infections in the intestine, while also regulating inflammation by affecting the human immune system. The gut microbiota and probiotics play a role not only in intestinal inflammation associated with tumor formation but also in regulating anti-cancer immune response. As a result, they associated with tumor progression and the effectiveness of anti-cancer therapies...
March 13, 2024: Life Sciences
https://read.qxmd.com/read/38489081/urolithin-a-exerts-anti-tumor-effects-on-gastric-cancer-via-activating-autophagy-hippo-axis-and-modulating-the-gut-microbiota
#17
JOURNAL ARTICLE
Yixiao Qiao, Qiaoyun Xia, Xukun Cao, Jingyuan Xu, Zhengdong Qiao, Longyun Wu, Zhirong Chen, Longbao Yang, Xiaolan Lu
Gastric cancer (GC) treatment regimens are still unsatisfactory. Recently, Urolithin A (UroA) has gained tremendous momentum due to its anti-tumor properties. However, the therapeutic effect and underlying mechanisms of UroA in GC are unclear. We explored the effects and related mechanisms of UroA on GC both in vivo and in vitro. A Cell Counting Kit-8 was used to determine the influence of UroA on the proliferation of GC cell lines. The Autophagy inhibitor 3-methyladenine (3MA) was employed to clarify the role of autophagy in the anti-tumor effect of UroA...
March 15, 2024: Naunyn-Schmiedeberg's Archives of Pharmacology
https://read.qxmd.com/read/38474387/role-of-inflammatory-mechanisms-in-major-depressive-disorder-from-etiology-to-potential-pharmacological-targets
#18
REVIEW
Bruna R Kouba, Laura de Araujo Borba, Pedro Borges de Souza, Joana Gil-Mohapel, Ana LĂșcia S Rodrigues
The involvement of central and peripheral inflammation in the pathogenesis and prognosis of major depressive disorder (MDD) has been demonstrated. The increase of pro-inflammatory cytokines (interleukin (IL)-1β, IL-6, IL-18, and TNF-α) in individuals with depression may elicit neuroinflammatory processes and peripheral inflammation, mechanisms that, in turn, can contribute to gut microbiota dysbiosis. Together, neuroinflammation and gut dysbiosis induce alterations in tryptophan metabolism, culminating in decreased serotonin synthesis, impairments in neuroplasticity-related mechanisms, and glutamate-mediated excitotoxicity...
February 28, 2024: Cells
https://read.qxmd.com/read/38444940/probiotics-as-modulators-of-gut-brain-axis-for-cognitive-development
#19
REVIEW
Akash Kumar, Bhagavathi Sundaram Sivamaruthi, Swarnima Dey, Yogesh Kumar, Rishabha Malviya, Bhupendra G Prajapati, Chaiyavat Chaiyasut
Various microbial communities reside in the gastrointestinal tract of humans and play an important role in immunity, digestion, drug metabolism, intestinal integrity, and protection from pathogens. Recent studies have revealed that the gut microbiota (GM) is involved in communication with the brain, through a bidirectional communication network known as the gut-brain axis. This communication involves humoral, immunological, endocrine, and neural pathways. Gut dysbiosis negatively impacts these communication pathways, leading to neurological complications and cognitive deficits...
2024: Frontiers in Pharmacology
https://read.qxmd.com/read/38422651/effect-of-icariin-on-depressive-behaviour-in-rat-pups-evidences-for-its-mechanism-of-action-by-integrating-network-pharmacology-metabolomics-and-gut-microbiota-composition
#20
JOURNAL ARTICLE
Yankai Dong, Lawen Wang, Mingge Yang, Xin Zhou, Ge Li, Kaixuan Xu, Yao Ma, Jinfeng Chen, Zhifei Wang, Jiahao Zhou, Hui Li, Zhongliang Zhu
BACKGROUND: Prenatal stress (PS) can cause cognitive disorder and a range of psychological illnesses, including anxiety and depression. Icariin (ICA) has shown promising effects in improving PS-induced depressive behaviour. However, its mechanism of action remains unclear. PURPOSE: This study was performed to reveal the key targets, metabolites and gut microbiota for ICA in improving depressive behaviour in PS rat pups. METHODS: A prenatal restraint stress animal model was established for Sprague-Dawley (SD) rats in late pregnancy...
February 5, 2024: Phytomedicine
keyword
keyword
36271
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.